The Reveal LINQ monitor developed by Medtronic identifies more people who have atrial fibrillation after a cryptogenic stroke (CS) – with no identified cause – or transient ischaemic attack (TIA).

Last year, for example, a review of more than 3,500 alerts in 61 patients with implanted heart monitors over the course of several months found high rates of false alerts with the devices ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

The NIM-Response® 3.0 and NIM-Neuro® 3.0 offer advanced nerve monitoring technology with an easy-to-use interface. NIM® systems monitor EMG activity from multiple mucles. If there is a change ...

Furthermore, in case of a symptomatic event (e.g. syncope or palpitations ... The Reveal XT™ (Medtronic Inc., Minneapolis, MN, USA) can monitor brady and tachyarrhythmias through manually ...

The potential for technology to create – and close – gaps in health equity Pulse oximetry – a global standard of care in patient monitoring ... pulse oximeter. 2 Medtronic Nellcor ...

confirmation and additional details will be provided closer to the specific event. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

For a range of hospitalized patients at risk of worsening heart failure (HF), tying medical interventions to cardiac ...

Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...